While strategies such as CSF-1R inhibition, immune checkpoint blockade, and nanotechnology-based interventions show potential in restoring immune function and inhibiting tumor progression, these approaches must be optimized to overcome TAM plasticity, spatial complexity, and delivery limitations. The gene discussed is CSF1R; the disease is neoplasm.